Cargando…
Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590818/ https://www.ncbi.nlm.nih.gov/pubmed/34786184 http://dx.doi.org/10.18632/oncotarget.27998 |
| _version_ | 1784599069162733568 |
|---|---|
| author | O’Shea, Anne E. Clifton, Guy T. Peoples, George E. |
| author_facet | O’Shea, Anne E. Clifton, Guy T. Peoples, George E. |
| author_sort | O’Shea, Anne E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8590818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85908182021-11-15 Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer O’Shea, Anne E. Clifton, Guy T. Peoples, George E. Oncotarget Editorial Impact Journals LLC 2021-11-09 /pmc/articles/PMC8590818/ /pubmed/34786184 http://dx.doi.org/10.18632/oncotarget.27998 Text en Copyright: © 2021 O’Shea et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial O’Shea, Anne E. Clifton, Guy T. Peoples, George E. Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer |
| title | Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer |
| title_full | Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer |
| title_fullStr | Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer |
| title_full_unstemmed | Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer |
| title_short | Results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for HER2-targeted therapy in triple-negative breast cancer |
| title_sort | results from a randomized trial combining trastuzumab with a peptide vaccine suggest a role for her2-targeted therapy in triple-negative breast cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590818/ https://www.ncbi.nlm.nih.gov/pubmed/34786184 http://dx.doi.org/10.18632/oncotarget.27998 |
| work_keys_str_mv | AT osheaannee resultsfromarandomizedtrialcombiningtrastuzumabwithapeptidevaccinesuggestaroleforher2targetedtherapyintriplenegativebreastcancer AT cliftonguyt resultsfromarandomizedtrialcombiningtrastuzumabwithapeptidevaccinesuggestaroleforher2targetedtherapyintriplenegativebreastcancer AT peoplesgeorgee resultsfromarandomizedtrialcombiningtrastuzumabwithapeptidevaccinesuggestaroleforher2targetedtherapyintriplenegativebreastcancer |